Literature DB >> 32069125

High Levels of Apoptosis Are Induced in the Human Colon Cancer HT-29 Cell Line by Co-Administration of Sulforaphane and a Peptide Nucleic Acid Targeting miR-15b-5p.

Jessica Gasparello1, Laura Gambari2, Chiara Papi1, Andrea Rozzi3, Alex Manicardi3, Roberto Corradini3, Roberto Gambari1, Alessia Finotti1.   

Abstract

Sulforaphane (SFN) is one of most important dietary constituents of broccoli (Brassica oleracea) and other cruciferous vegetables, which have been reported to exhibit health benefits, including prevention and therapy of cancer, such as colorectal carcinoma (CRC). The objective of this study was to determine whether the anticancer effect of SFN on colon cancer HT-29 cell line could be improved by the combined treatment with molecules inhibiting microRNAs (miRNAs) involved in CRC. As miRNA inhibiting molecules we focused on peptide-nucleic acids (PNAs). As miRNA to be targeted, miR-15b-5p was selected on the basis of several information present in the literature and confirming that miR-15b-5p is overexpressed in colon cancer patients, and that its targeting decreases cell migration and metastasis in colorectal cancer. In this article, we described for the first time the efficacy of targeting miR-15b-5p by using a PNA against miR-15b-5p (R8-PNA-a15b), functionalized with an octoarginine peptide (R8) for maximizing cellular uptake. The miR-15b-5p downregulation in the colon cancer HT-29 cell line was associated with inhibition of in vitro cell growth and activation of the proapoptotic pathway, demonstrated by a sharp increase of late apoptotic cells in HT-29-treated cell populations. A second conclusion of this study is that the R8-PNA-a15b might be proposed in "combo-therapy" associated with SFN. To our knowledge, no report is available in the literature on a combination between SFN and miRNA-targeting molecules. Our data demonstrate that this combined treatment leads to a very high proportion of apoptotic HT-29 cells (over 85%), a value higher than the sum of the values of apoptotic cells obtained after singularly administered regents (either SFN or R8-PNA-a15b).

Entities:  

Keywords:  apoptosis; colon cancer; miR-15b-5p; miRNA targeting; microRNAs; peptide nucleic acids; sulforaphane

Year:  2020        PMID: 32069125     DOI: 10.1089/nat.2019.0825

Source DB:  PubMed          Journal:  Nucleic Acid Ther        ISSN: 2159-3337            Impact factor:   5.486


  12 in total

1.  Combined Broccoli Sprouts and Green Tea Polyphenols Contribute to the Prevention of Estrogen Receptor-Negative Mammary Cancer via Cell Cycle Arrest and Inducing Apoptosis in HER2/neu Mice.

Authors:  Shizhao Li; Huixin Wu; Trygve O Tollefsbol
Journal:  J Nutr       Date:  2021-01-04       Impact factor: 4.798

2.  Synergistic Effects of A Combined Treatment of Glioblastoma U251 Cells with An Anti-miR-10b-5p Molecule and An AntiCancer Agent Based on 1-(3',4',5'-Trimethoxyphenyl)-2-Aryl-1H-Imidazole Scaffold.

Authors:  Matteo Zurlo; Romeo Romagnoli; Paola Oliva; Jessica Gasparello; Alessia Finotti; Roberto Gambari
Journal:  Int J Mol Sci       Date:  2022-05-26       Impact factor: 6.208

3.  Inhibition of microRNA-15b-5p Attenuates the Progression of Oral Squamous Cell Carcinoma via Modulating the PTPN4/STAT3 Axis.

Authors:  Xuerong Liu; Yuanyuan Dong; Dan Song
Journal:  Cancer Manag Res       Date:  2020-10-28       Impact factor: 3.989

4.  Nutritional combinatorial impact on the gut microbiota and plasma short-chain fatty acids levels in the prevention of mammary cancer in Her2/neu estrogen receptor-negative transgenic mice.

Authors:  Manvi Sharma; Itika Arora; Matthew L Stoll; Yuanyuan Li; Casey D Morrow; Stephen Barnes; Taylor F Berryhill; Shizhao Li; Trygve O Tollefsbol
Journal:  PLoS One       Date:  2020-12-31       Impact factor: 3.240

5.  Exploring a peptide nucleic acid-based antisense approach for CD5 targeting in chronic lymphocytic leukemia.

Authors:  Elena Cesaro; Andrea Patrizia Falanga; Rosa Catapano; Francesca Greco; Simona Romano; Nicola Borbone; Arianna Pastore; Maria Marzano; Federico Chiurazzi; Stefano D'Errico; Gennaro Piccialli; Giorgia Oliviero; Paola Costanzo; Michela Grosso
Journal:  PLoS One       Date:  2022-03-31       Impact factor: 3.240

6.  Treatment of Human Glioblastoma U251 Cells with Sulforaphane and a Peptide Nucleic Acid (PNA) Targeting miR-15b-5p: Synergistic Effects on Induction of Apoptosis.

Authors:  Jessica Gasparello; Chiara Papi; Matteo Zurlo; Laura Gambari; Andrea Rozzi; Alex Manicardi; Roberto Corradini; Roberto Gambari; Alessia Finotti
Journal:  Molecules       Date:  2022-02-15       Impact factor: 4.411

Review 7.  Two Worlds Colliding: The Interplay Between Natural Compounds and Non-Coding Transcripts in Cancer Therapy.

Authors:  Alexandru A Sabo; Maria Dudau; George L Constantin; Tudor C Pop; Christoph-M Geilfus; Alessio Naccarati; Mihnea P Dragomir
Journal:  Front Pharmacol       Date:  2021-07-06       Impact factor: 5.810

8.  Sulforaphane inhibits the expression of interleukin-6 and interleukin-8 induced in bronchial epithelial IB3-1 cells by exposure to the SARS-CoV-2 Spike protein.

Authors:  Jessica Gasparello; Elisabetta D'Aversa; Chiara Papi; Laura Gambari; Brunella Grigolo; Monica Borgatti; Alessia Finotti; Roberto Gambari
Journal:  Phytomedicine       Date:  2021-05-04       Impact factor: 5.340

9.  Glucoraphanin Increases Intracellular Hydrogen Sulfide (H2S) Levels and Stimulates Osteogenic Differentiation in Human Mesenchymal Stromal Cell.

Authors:  Laura Gambari; Marli Barone; Emanuela Amore; Brunella Grigolo; Giuseppe Filardo; Renato Iori; Valentina Citi; Vincenzo Calderone; Francesco Grassi
Journal:  Nutrients       Date:  2022-01-19       Impact factor: 5.717

10.  Synergistic effects of the combined treatment of U251 and T98G glioma cells with an anti‑tubulin tetrahydrothieno[2,3‑c]pyridine derivative and a peptide nucleic acid targeting miR‑221‑3p.

Authors:  Matteo Zurlo; Romeo Romagnoli; Paola Oliva; Jessica Gasparello; Alessia Finotti; Roberto Gambari
Journal:  Int J Oncol       Date:  2021-07-19       Impact factor: 5.650

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.